Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy

NCT00004249 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: QS21
BIOLOGICAL: keyhole limpet hemocyanin
DRUG: polysialic acid

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]